comparemela.com

Page 4 - Michael Difiore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Halozyme Therapeutics, Inc (NASDAQ:HALO) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, my name is Chris and I ll be your conference operator today.

United statesRoche phesgoDavid risingerEun yangJessica fyeHelen torleyNicole labrosseMichael difioreCaroline palomequeMohit bansalCorinne jenkinsJason butlerWells fargoHalozyme therapeutics incEuropean medical agencyAntares pharma

Intra-Cellular Therapies, Inc (NASDAQ:ITCI) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to Intra-Cellular Therapies First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.

United statesAndrew tsaiMichael difioreJuan sanchezDavid amsellemLarry hinelineSuresh durgamCanaccord genuityCorinne jenkinsBrian abrahamsMark neumannLeonid timashevMarc goodmanVardhman chhajedVraylar abilifySumant kulkarni

CinCor shares dive after blood pressure drug fails key trial

BioPharma

Cincor pharmaMichael difioreDive briefDennis dingNew england journalUmer raffatClinical trials

Amylyx Pharmaceuticals, Inc (AMLX) Q3 2022 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AMLX) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Lindsey Allen - Head of Investor Relations and.

United statesNeena bitritto gargJosh cohenMichael difioreMike difioreTammy sarnelliJim fratesJustin kleeMargaret olingerMarc goodmanJames fratesAndrew feinCorinne jenkinsLindsey allenCompany participantsAmylyx pharmaceuticals inc

In unusual move, FDA to reconvene advisers for ALS drug review

BioPharma

Tammy sarnelliMichael difioreAmylyx pharmaceuticalsDrug administrationHealth canadaDive briefUmer raffat

vimarsana © 2020. All Rights Reserved.